Amneal Pharmaceuticals Financials
| 2DT Stock | EUR 7.30 0.25 3.31% |
Amneal |
Understanding current and past Amneal Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amneal Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Amneal Pharmaceuticals' assets may result in an increase in income on the income statement.
Amneal Pharmaceuticals Stock Summary
Amneal Pharmaceuticals competes with Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, NorAm Drilling, and BANK HANDLOWY. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey. AMNEAL PHMCTCLS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6000 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US03168L1052 |
| Business Address | 400 Crossing Boulevard, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.amneal.com |
| Phone | 908 947 3120 |
| Currency | EUR - Euro |
You should never invest in Amneal Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amneal Stock, because this is throwing your money away. Analyzing the key information contained in Amneal Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amneal Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Amneal Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amneal Pharmaceuticals reports annually and quarterly.| Return On Equity | -0.88 | |||
| Return On Asset | 0.0257 | |||
| Target Price | 7.33 | |||
| Beta | 1.37 |
Amneal Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amneal Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Amneal Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amneal Pharmaceuticals competition to find correlations between indicators driving Amneal Pharmaceuticals's intrinsic value. More Info.Amneal Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amneal Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Amneal Pharmaceuticals Systematic Risk
Amneal Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amneal Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Amneal Pharmaceuticals correlated with the market. If Beta is less than 0 Amneal Pharmaceuticals generally moves in the opposite direction as compared to the market. If Amneal Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amneal Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amneal Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Amneal Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Amneal Pharmaceuticals December 20, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amneal Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amneal Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amneal Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Amneal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amneal Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.95 | |||
| Information Ratio | 0.0105 | |||
| Maximum Drawdown | 16.1 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 5.37 |
Complementary Tools for Amneal Stock analysis
When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |